Stock comparison
LeMaitre Vascular
Medpace Holdings
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.32B
Sector
Healthcare
MEDP
Medpace Holdings
Market cap
$11.86B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | MEDP | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 53C | LMAT |
| Benjamin Graham | 81A | 59C | LMAT |
| Philip Fisher | 73B | 62C | LMAT |
| Peter Lynch | 59C | 57C | LMAT |
| Joel Greenblatt | 48D | 71B | MEDP |
| Charlie Munger | 60C | 59C | LMAT |
| Terry Smith | 61C | 67B | MEDP |
Side-by-side metrics
| Metric | LMAT | MEDP |
|---|---|---|
| Market cap | $2.32B | $11.86B |
| P/E (TTM) | 37.1x | 25.7x |
| EV/EBIT | 36.6x | 21.2x |
| ROIC (TTM) | 9.43% | 56.06% |
| Gross margin | 72.39% | 29.07% |
| Net margin | 24.35% | 17.19% |
| Revenue CAGR 5y | 12.75% | 21.99% |
| EPS CAGR 5y | 19.04% | 32.59% |
| Debt / Equity | 0.5x | 0.2x |
| Dividend yield | 0.84% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Gross margin72.39%vs 29.07%+60%
- Net margin24.35%vs 17.19%+29%
MEDP leads on
- ROIC (TTM)56.06%vs 9.43%+83%
- Market cap$11.86Bvs $2.32B+80%
- Debt / Equity0.2xvs 0.5x+48%
- EV/EBIT21.2xvs 36.6x+42%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.